Upstream Bio, Inc. (UPB) Q1 2025 Earnings
UPB·Reported May 6, 2025·Before market open
Upstream Bio, Inc. reported Q1 2025 revenue of $566.0K, beat analyst consensus of $317.0K by $249.0K. Diluted EPS came in at $-0.51, missed the $-0.49 consensus by $0.02.
Revenue
$566.0Kbeat by $249.0K
Consensus: $317.0KDiluted EPS
$-0.51missed by $0.02
Consensus: $-0.49
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Upstream Bio, Inc.'s Q1 2025 earnings report.
Upstream Bio, Inc. (UPB) reported Q1 2025 earnings on May 6, 2025 before market open.
Upstream Bio, Inc. reported revenue of $566.0K and diluted EPS of $-0.51 for Q1 2025.
Revenue beat the consensus estimate of $317.0K by $249.0K. EPS missed the consensus estimate of $-0.49 by $0.02.
You can read the 10-Q periodic report (0000950170-25-063957) directly on SEC EDGAR. The filing index links above go to sec.gov.